SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat lupus kidney disease
Disease control Not yet recruitingThis early study tests a new treatment called CHT105 for people with lupus nephritis that hasn't responded to standard therapies. CHT105 uses specially engineered immune cells from healthy donors to target and destroy the faulty immune cells driving the disease. The main goals ar…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Apr 28, 2026 21:35 UTC
-
Lupus drug showdown: which treatment works best?
Disease control Not yet recruitingThis study compares two drugs, telitacicept and belimumab, for people with systemic lupus erythematosus (SLE), a chronic autoimmune disease. Researchers want to see which drug better controls lupus symptoms and kidney problems. About 180 adults aged 18-65 will choose their treatm…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Sponsor: Yipeng Liu • Aim: Disease control
Last updated Apr 28, 2026 21:35 UTC
-
New lupus drug TQH3906 enters phase 2 testing
Disease control Not yet recruitingThis study tests whether a new medicine called TQH3906 can help control lupus, a chronic autoimmune disease. About 198 adults with lupus will receive either TQH3906 or a placebo. The main goal is to see if more people on the drug achieve a meaningful reduction in lupus activity b…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Apr 28, 2026 21:35 UTC